Acute generalized exanthematous pustulosis in a patient after stem cell transplantation
Language English Country United States Media print
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Acitretin administration & dosage MeSH
- Acute Generalized Exanthematous Pustulosis drug therapy immunology pathology MeSH
- Anti-Inflammatory Agents administration & dosage MeSH
- Keratolytic Agents administration & dosage MeSH
- Drug Therapy, Combination MeSH
- Skin pathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Methylprednisolone administration & dosage MeSH
- Multiple Myeloma surgery MeSH
- Postoperative Complications immunology MeSH
- Recurrence MeSH
- Hematopoietic Stem Cell Transplantation * MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Acitretin MeSH
- Anti-Inflammatory Agents MeSH
- Keratolytic Agents MeSH
- Methylprednisolone MeSH
BACKGROUND: a severe generalized pustular eruption occurred several months after allogeneic hematopoietic stem cell transplantation for multiple myeloma in a patient being treated with antibiotics for respiratory infection. Neither he nor his donor had a history of psoriasis. METHODS: the patient was treated with drug withdrawal and administration of cyclosporine and methylprednisolone without improvement; later, acitretin and methylprednisolone were used successfully. The eruption slowly subsided, and therapy was discontinued. Four months later, the patient experienced a recurrent severe pustular eruption associated with fever and leukocytosis, and the same treatment was used successfully again. RESULTS AND CONCLUSION: the patient has not experienced relapses in the ensuing 3 years. Acute generalized exanthematous pustulosis is a rare cutaneous adverse reaction triggered most commonly by drugs with a tendency to resolve spontaneously. The surprisingly prolonged, refractory, and relapsing course of the eruption in our patient might be due to the immune alteration and the polypharmacologic therapy after stem cell transplantation.
References provided by Crossref.org